The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scher, H. I., Halabi, S., Tannock, I., Morris, M., Sternberg, C. N., Carducci, M. A., Eisenberger, M. A., Higano, C., Bubley, G. J., Dreicer, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4487 · Cited by 2,241
(1997) · PubMed · Cited by 1,541
Perera, M., Papa, N., Christidis, D., Wetherell, D., Hofman, M. S., Murphy, D. G., Bolton, D., & Lawrentschuk, N. (2016) · European Urology · doi:10.1016/j.eururo.2016.06.021 · Cited by 1,007
Eiber, M., Maurer, T., Souvatzoglou, M., Beer, A. J., Ruffani, A., Haller, B., Graner, F.-P., Kübler, H., Haberhorn, U., Eisenhut, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154153 · Cited by 994
Self-citationAfshar-Oromieh, A., Avtzi, E., Giesel, F. L., Holland-Letz, T., Linhart, H. G., Eder, M., Eisenhut, M., Boxler, S., Hadaschik, B. A., Kratochwil, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2949-6 · Cited by 964
Self-citationAfshar-Oromieh, A., Zechmann, C. M., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Holland-Letz, T., Hadaschik, B. A., Giesel, F. L., Debus, J., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2525-5 · Cited by 921
Self-citationAfshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2298-2 · Cited by 915
Self-citation68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Eder, M., Schäfer, M., Bauder-Wüst, U., Hull, W.-E., Wängler, C., Mier, W., Haberkorn, U., & Eisenhut, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200279b · Cited by 843
Self-citationChang, S. S., Reuter, V. E., Heston, W. D. W., Bander, N. H., Grauer, L. S., & Gaudin, P. B. (1999) · PubMed · Cited by 825
Maurer, T., Gschwend, J. E., Rauscher, I., Souvatzoglou, M., Haller, B., Weirich, G., Wester, H.-J., Heck, M., Kübler, H., Beer, A. J., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.12.025 · Cited by 779
Self-citationBaughman, R. P., Lower, E. E., & du Bois, R. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12888-7 · Cited by 657
Current use of PSMA–PET in prostate cancer management
Maurer, T., Eiber, M., Schwaiger, M., & Gschwend, J. E. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.26 · Cited by 611
Self-citationExpression of the prostate-specific membrane antigen.
Israeli, R., Powell, C. T., Corr, J., Fair, W. R., & Heston, W. D. W. (1994) · PubMed · Cited by 601
Giesel, F. L., Hadaschik, B., Cardinale, J., Radtke, J., Vinsensia, M., Lehnert, W., Kesch, C., Tolstov, Y., Singer, S., Grabe, N., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3573-4 · Cited by 592
Self-citationMorigi, J. J., Stricker, P. D., van Leeuwen, P. J., Tang, R., Ho, B., Nguyen, Q., Hruby, G., Fogarty, G., Jagavkar, R., Kneebone, A., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160382 · Cited by 571
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Epstein, J. I., Amin, M. B., Beltran, H., Lotan, T. L., Mosquera, J.-M., Reuter, V. E., Robinson, B. D., Troncoso, P., & Rubin, M. A. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000208 · Cited by 569
Baum, R. P., Kulkarni, H. R., Schuchardt, C., Singh, A., Wirtz, M., Wiessalla, S., Schottelius, M., Mueller, D., Klette, I., & Wester, H.-J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168443 · Cited by 525
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
Szabo, Z., Mena, E., Rowe, S. P., Plyku, D., Nidal, R., Eisenberger, M. A., Antonarakis, E. S., Fan, H., Dannals, R. F., Chen, Y., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0850-8 · Cited by 443
Self-citationChen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Self-citationGlobal Burden of Urologic Cancers, 1990–2013
Dy, G. W., Gore, J. L., Forouzanfar, M. H., Naghavi, M., & Fitzmaurice, C. (2017) · European Urology · doi:10.1016/j.eururo.2016.10.008 · Cited by 373
Zechmann, C. M., Afshar-Oromieh, A., Armor, T., Stubbs, J. B., Mier, W., Hadaschik, B., Joyal, J., Kopka, K., Debus, J., Babich, J. W., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2713-y · Cited by 358
Self-citationDietlein, M., Kobe, C., Kuhnert, G., Stockter, S., Fischer, T., Schomäcker, K., Schmidt, M., Dietlein, F., Zlatopolskiy, B. D., Krapf, P., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0866-0 · Cited by 355
van Leeuwen, P. J., Emmett, L., Ho, B., Delprado, W., Ting, F., Nguyen, Q. A., & Stricker, P. D. (2016) · British Journal of Urology · doi:10.1111/bju.13540 · Cited by 329
Afshar-Oromieh, A., Haberkorn, U., Eder, M., Eisenhut, M., & Zechmann, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2069-0 · Cited by 325
Self-citationThe biology and treatment of oligometastatic cancer
Reyes, D. K., & Pienta, K. J. (2015) · Oncotarget · doi:10.18632/oncotarget.3455 · Cited by 320
Self-citationEvans, M. J., Smith-Jones, P. M., Wongvipat, J., Navarro, V., Kim, S., Bander, N. H., Larson, S. M., & Sawyers, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106383108 · Cited by 316
Hillier, S. M., Maresca, K. P., Femia, F. J., Marquis, J. C., Foss, C. A., Nguyen, N., Zimmerman, C. N., Barrett, J. A., Eckelman, W. C., Pomper, M. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1682 · Cited by 316
Self-citationMaresca, K. P., Hillier, S. M., Femia, F. J., Keith, D., Barone, C., Joyal, J. L., Zimmerman, C. N., Kozikowski, A. P., Barrett, J. A., Eckelman, W. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800994j · Cited by 295
Ahmadzadehfar, H., Eppard, E., Kürpig, S., Fimmers, R., Yordanova, A., Schlenkhoff, C. D., Gärtner, F., Rogenhofer, S., & Essler, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7245 · Cited by 282
Cho, S. Y., Gage, K. L., Mease, R. C., Senthamizhchelvan, S., Holt, D. P., Jeffrey-Kwanisai, A., Endres, C. J., Dannals, R. F., Sgouros, G., Lodge, M., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.104661 · Cited by 279
Self-citationComparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography
Sanchez-Crespo, A. (2013) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2012.06.034 · Cited by 276
Rowe, S. P., Macura, K. J., Mena, E., Blackford, A. L., Nadal, R., Antonarakis, E. S., Eisenberger, M., Carducci, M., Fan, H., Dannals, R. F., et al. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0957-6 · Cited by 258
Self-citationThe Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer
Afshar-Oromieh, A., Babich, J. W., Kratochwil, C., Giesel, F. L., Eisenhut, M., Kopka, K., & Haberkorn, U. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170720 · Cited by 257
Self-citationJackson, P. F., Cole, D. C., Slusher, B. S., Stetz, S. L., Ross, L. E., Donzanti, B. A., & Trainor, D. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950801q · Cited by 256
van Leeuwen, P. J., Stricker, P., Hruby, G., Kneebone, A., Ting, F., Thompson, B., Nguyen, Q., Ho, B., & Emmett, L. (2016) · BJU International · doi:10.1111/bju.13397 · Cited by 256
Cardinale, J., Schäfer, M., Benešová, M., Bauder-Wüst, U., Leotta, K., Eder, M., Neels, O. C., Haberkorn, U., Giesel, F. L., & Kopka, K. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181768 · Cited by 249
Self-citationThe Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
Terry, S., & Beltran, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00060 · Cited by 238
Haffner, M. C., Kronberger, I. E., Ross, J. S., Sheehan, C. E., Zitt, M., Mühlmann, G., Öfner, D., Zelger, B., Ensinger, C., Yang, X. J., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.003 · Cited by 236
Hillier, S. M., Maresca, K. P., Lu, G., Merkin, R. D., Marquis, J. C., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.116624 · Cited by 230
Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
Beltran, H., Tagawa, S. T., Park, K., MacDonald, T., Milowsky, M. I., Mosquera, J. M., Rubin, M. A., & Nanus, D. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5166 · Cited by 229
Mease, R. C., Dusich, C. L., Foss, C. A., Ravert, H. T., Dannals, R. F., Seidel, J., Prideaux, A., Fox, J. J., Sgouros, G., Kozikowski, A. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1517 · Cited by 223
Self-citationNeuroendocrine differentiation of prostate cancer: a review.
Parimi, V., Goyal, R., Poropatich, K., & Yang, X. J. (2014) · Europe PMC (PubMed Central) · Cited by 215
68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
Hope, T. A., Truillet, C., Ehman, E. C., Afshar-Oromieh, A., Aggarwal, R., Ryan, C. J., Carroll, P. R., Small, E. J., & Evans, M. J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181800 · Cited by 214
Self-citationNeuroendocrine differentiation in prostate cancer – a review
Carol Davila Central Emergency Military Hospital, B., Popescu, R., Bratu, O., Carol Davila Central Emergency Military Hospital, B., Carol Davila University of Medicine and Pharmacy, F. O. M., Spînu, D., Carol Davila Central Emergency Military Hospital, B., Marcu, D., Carol Davila Central Emergency Military Hospital, B., Farcaș, C., et al. (2015) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2015.118.3.3 · Cited by 210
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Rauscher, I., Maurer, T., Fendler, W. P., Sommer, W. H., Schwaiger, M., & Eiber, M. (2016) · Cancer Imaging · doi:10.1186/s40644-016-0072-6 · Cited by 208
Self-citation18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
Rowe, S. P., Gage, K. L., Faraj, S. F., Macura, K. J., Cornish, T. C., Gonzalez-Roibon, N., Guner, G., Munari, E., Partin, A. W., Pavlovich, C. P., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154336 · Cited by 196
Self-citationKulkarni, H. R., Singh, A., Schuchardt, C., Niepsch, K., Sayeg, M., Leshch, Y., Wester, H.-J., & Baum, R. P. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170167 · Cited by 192
Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
Afshar-Oromieh, A., Hetzheim, H., Kübler, W., Kratochwil, C., Giesel, F. L., Hope, T. A., Eder, M., Eisenhut, M., Kopka, K., & Haberkorn, U. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3419-0 · Cited by 185
Self-citationKrohn, T., Verburg, F. A., Pufe, T., Neuhuber, W., Vogg, A., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2915-3 · Cited by 180
Dietlein, F., Kobe, C., Neubauer, S., Schmidt, M., Stockter, S., Fischer, T., Schomäcker, K., Heidenreich, A., Zlatopolskiy, B. D., Neumaier, B., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185538 · Cited by 180
Ristau, B. T., O'Keefe, D. S., & Bacich, D. J. (2014) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.09.003 · Cited by 178
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Rowe, S. P., Gorin, M. A., Hammers, H. J., Som Javadi, M., Hawasli, H., Szabo, Z., Cho, S. Y., Pomper, M. G., & Allaf, M. E. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-015-1017-z · Cited by 172
Self-citationMeller, B., Bremmer, F., Sahlmann, C. O., Hijazi, S., Bouter, C., Trojan, L., Meller, J., & Thelen, P. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0145-8 · Cited by 165
PSMA as a target for radiolabelled small molecules
Eder, M., Eisenhut, M., Babich, J. W., & Haberkorn, U. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2374-2 · Cited by 149
Self-citationImpact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
Hope, T. A., Aggarwal, R. R., Chee, B. H., Tao, D. H., Greene, K. L., Cooperberg, M. R., Feng, F. Y.-C., Chang, A. J., Ryan, C. J., Small, E. J., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192476 · Cited by 143
68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma
Demirci, E., Ocak, M., Kabasakal, L., Decristoforo, C., Talat, Z., Halaç, M., & Kanmaz, B. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2766-y · Cited by 140
Pomper, M. G., Musachio, J. L., Zhang, J., Scheffel, U., Zhou, Y., Hilton, J., Maini, A., Dannals, R. F., Wong, D. F., & Kozikowski, A. P. (2002) · Molecular Imaging · doi:10.1162/153535002320162750 · Cited by 138
Self-citationKabasakal, L., Demirci, E., Ocak, M., Akyel, R., Nematyazar, J., Aygün, A., Halaç, M., Talat, Z., & Araman, A. O. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000290 · Cited by 138
Rhee, H., Blazak, J., Tham, C. M., Ng, K. L., Shepherd, B., Lawson, M., Preston, J. M., Vela, I., Thomas, P. A., & Wood, S. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0231-6 · Cited by 138
Pyka, T., Weirich, G., Einspieler, I., Maurer, T., Theisen, J., Hatzichristodoulou, G., Schwamborn, K., Schwaiger, M., & Eiber, M. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.164442 · Cited by 133
Self-citationAfshar‐Oromieh, A., Sattler, L. P., Mier, W., Hadaschik, B. A., Debus, J., Holland‐Letz, T., Kopka, K., & Haberkorn, U. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183483 · Cited by 133
Self-citationFirst evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
Verburg, F. A., Krohn, T., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3065-y · Cited by 132
Marchal, C., Redondo, M., Padilla, M., Caballero, J., Rodrigo, I., Garcia, J., Quian, J., & Boswick, D. G. (2004) · PubMed · doi:10.14670/hh-19.715 · Cited by 129
Rischpler, C., Beck, T. I., Okamoto, S., Schlitter, A. M., Knorr, K., Schwaiger, M., Gschwend, J. E., Maurer, T., Meyer, P. T., & Eiber, M. J. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.204677 · Cited by 128
Self-citationKasperzyk, J. L., Finn, S. P., Flavin, R., Fiorentino, M., Lis, R. L., Hendrickson, W. K., Clinton, S. K., Sesso, H. D., Giovannucci, E. L., Stampfer, M. J., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0668 · Cited by 127
Imaging metastatic bone disease from carcinoma of the prostate
Messiou, C., Cook, G., & deSouza, N. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605334 · Cited by 124
64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
Banerjee, S. R., Pullambhatla, M., Foss, C. A., Nimmagadda, S., Ferdani, R., Anderson, C. J., Mease, R. C., & Pomper, M. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401921j · Cited by 122
Self-citationRowe, S. P., Macura, K. J., Ciarallo, A., Mena, E., Blackford, A. L., Nadal, R., Antonarakis, E. S., Eisenberger, M. A., Carducci, M. A., Ross, A. E., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.163782 · Cited by 115
Self-citation68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma
Sasikumar, A., Joy, A., Nanabala, R., Pillai, M. R. A., Thomas, B., & Vikraman, K. R. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3297-x · Cited by 113
Kesch, C. V., Vinsensia, M., Radtke, J. P., Schlemmer, H. P., Heller, M., Ellert, E., Holland‐Letz, T., Duensing, S. M., Grabe, N., Afshar‐Oromieh, A., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.189233 · Cited by 108
Self-citationSawicki, L. M., Buchbender, C., Boos, J., Giessing, M., Ermert, J., Antke, C., Antoch, G., & Hautzel, H. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3360-2 · Cited by 104
Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT
Artigas, C., Alexiou, J., Garcia, C. A., Wimana, Z., Otte, F.-X., Gil, T., Velthoven, R. V., & Flamen, P. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3236-x · Cited by 98
Prasad, V., Steffen, I. G., Diederichs, G., Makowski, M. R., Wust, P., & Brenner, W. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0945-x · Cited by 97
Prostate-specific membrane antigen expression in regeneration and repair
Gordon, I. O., Tretiakova, M., Noffsinger, A. E., Hart, J. A. L., Reuter, V. E., & Al‐Ahmadie, H. A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.143 · Cited by 93
Pillai, M. R. A., Nanabala, R., Joy, A., Sasikumar, A., & Knapp, F. F. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.08.006 · Cited by 91
Pfob, C. H., Ziegler, S. I., Graner, F. P., Köhner, M., Schachoff, S., Blechert, B., Wester, H., Scheidhauer, K., Schwaiger, M., Maurer, T., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3424-3 · Cited by 87
Self-citationChakraborty, P. S., Tripathi, M., Agarwal, K. K., Kumar, R., Vijay, M. K., & Bal, C. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000594 · Cited by 84
Hillier, S., Kern, A. M., Maresca, K. P., Marquis, J. C., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086751 · Cited by 84
Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
Sahlmann, C., Meller, B., Bouter, C., Ritter, C. O., Ströbel, P., Lotz, J., Trojan, L., Meller, J., & Hijazi, S. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3251-y · Cited by 82
Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis
Kobe, C., Maintz, D. C., Fischer, T. H., Drzezga, A. E., & Chang, D. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000827 · Cited by 80
Foss, C. A., Mease, R. C., Cho, S. Y., Kim, H. J., & Pomper, M. G. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799462612 · Cited by 79
Self-citationFollicular Thyroid Adenoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT
Kanthan, G. L., Drummond, J., Schembri, G. P., Izard, M. A., & Hsiao, E. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001084 · Cited by 79
Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non–Small Cell Lung Cancer
Shetty, D., Loh, H., Bui, C., Mansberg, R., & Stevanovic, A. G. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001139 · Cited by 77
Tosoian, J. J., Gorin, M. A., Rowe, S. P., Andreas, D., Szabó, Z. R., Pienta, K. J., Pomper, M. G., Lotan, T. L., & Ross, A. E. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.09.002 · Cited by 77
Self-citationDesign of NAALADase Inhibitors A Novel Neuroprotective Strategy
Jackson, P., & Slusher, B. S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372797 · Cited by 75
68Ga-PSMA imaging of metastatic breast cancer
Sathekge, M. M., Modiselle, M., Vorster, M., Mokgoro, N. P., Nyakale, N. E., Mokaleng, B., & Ebenhan, T. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3066-x · Cited by 73
Rectal Carcinoma on 68Ga-PSMA PET/CT
Huang, Y.-T. T., Fong, W., & Thomas, P. A. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001072 · Cited by 73
Rischpler, C., Maurer, T., Schwaiger, M., & Eiber, M. J. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3235-y · Cited by 69
Self-citationFollicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT
Kanthan, G. L., Coyle, L. A., Kneebone, A. B., Schembri, G. P., & Hsiao, E. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001169 · Cited by 65
Subacute Stroke Mimicking Cerebral Metastasis in 68Ga-PSMA-HBED-CC PET/CT
Noto, B., Vrachimis, A., Schäfers, M. A., Stegger, L., & Rahbar, K. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001291 · Cited by 62
Fendler, W. P., Lechner, H., Todica, A. S., Paprottka, K. J., Paprottka, P. M., Jakobs, T. F., Michl, M., Bartenstein, P., Lehner, S., & Haug, A. R. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.165050 · Cited by 61
68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease
Sasikumar, A., Joy, A., Nanabala, R., Pillai, M. R. A., & Hari, T. A. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001340 · Cited by 59
Expression of prostate-specific membrane antigen in renal cortical tumors
Al‐Ahmadie, H. A., Olgac, S., Gregor, P. D., Tickoo, S. K., Fine, S. W., Kondagunta, G. V., Scher, H. I., Morris, M. J., Russo, P., Motzer, R. J., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.42 · Cited by 57
Rowe, S. P., Gorin, M. A., Hammers, H. J., Pomper, M. G., Allaf, M. E., & Javadi, M. S. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000995 · Cited by 57
Self-citationVertebral Hemangioma Mimicking Bone Metastasis in 68Ga—PSMA Ligand PET/CT
Artigas, C., Otte, F.-X., Lemort, M., van Velthoven, R., & Flamen, P. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001631 · Cited by 56
Usmani, S., Ahmed, N., Marafi, F., Rasheed, R., Amanguno, H. G., & Kandari, F. A. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001618 · Cited by 53
PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma
Wang, W., Tavora, F. R. F., Sharma, R. B., Eisenberger, M., & Netto, G. J. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.04.007 · Cited by 52
Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma
Bhardwaj, H., Stephens, M., Bhatt, M. K., & Thomas, P. A. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001384 · Cited by 51
PSMA Uptake in Mediastinal Sarcoidosis
Ardies, P. J., Gykiere, P., Goethals, L., Mey, J. D., Geeter, F. D., & Everaert, H. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001543 · Cited by 50
Gorin, M. A., Rowe, S. P., Hooper, J. E., Kates, M. R., Hammers, H.-J., Szabó, Z. R., Pomper, M. G., & Allaf, M. E. (2016) · European Urology · doi:10.1016/j.eururo.2016.06.019 · Cited by 49
Self-citationProstate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis
Hermann, R. M., Djannatian, M., Czech, N., & Nitsche, M. (2016) · Case Reports in Oncology · doi:10.1159/000447688 · Cited by 49
Metastases From Colorectal Cancer Avid on 68Ga-PSMA PET/CT
Hangaard, L., Jochumsen, M. R., Vendelbo, M. H., & Bouchelouche, K. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001700 · Cited by 46
Bilgin, R., Ergül, N., & Çermik, T. F. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001406 · Cited by 45
Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CT
Kanthan, G. L., Hsiao, E., Kneebone, A. B., Eade, T., & Schembri, G. P. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001192 · Cited by 42
Gallium‐68 PSMA uptake in adrenal adenoma
Law, W. P., Fiumara, F., Fong, W., & Miles, K. A. (2015) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12357 · Cited by 41
Prostate-Specific Membrane Antigen PET/CT: Uptake in Lymph Nodes With Active Sarcoidosis
Dias, A. H., Vendelbo, M. H., & Bouchelouche, K. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001528 · Cited by 37
Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT
Kanthan, G. L., Izard, M. A., Emmett, L., Hsiao, E., & Schembri, G. P. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001281 · Cited by 36
Paget Disease: A Potential Pitfall in PSMA PET for Prostate Cancer
Blazak, J., & Thomas, P. A. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001296 · Cited by 35
Zacho, H. D., Nielsen, J. B., Dettmann, K., Haberkorn, U., & Petersen, L. J. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001522 · Cited by 35
Self-citation68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases
Einspieler, I., Tauber, R., Maurer, T., Schwaiger, M., & Eiber, M. J. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001128 · Cited by 34
Self-citationAspecific Uptake of 68GA-PSMA in Paget Disease of the Bone
Bourgeois, S., Gykiere, P., Goethals, L., Everaert, H., & Geeter, F. D. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001335 · Cited by 33
Uprimny, C., Kroiss, A. S., Nilica, B., Buxbaum, S., Decristoforo, C., Horninger, W., & Virgolini, I. J. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2922-4 · Cited by 32
Rowe, S. P., Deville, C., Paller, C. J., Cho, S. Y., Fishman, E. K., Pomper, M. G., Ross, A. E., & Gorin, M. A. (2015) · Tomography · doi:10.18383/j.tom.2015.00169 · Cited by 31
Self-citationPulmonary Opacities and Bronchiectasis Avid on 68Ga-PSMA PET
Bouchelouche, K., & Vendelbo, M. H. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001568 · Cited by 31
Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT
Lawhn-Heath, C. A., Flavell, R. R., Glastonbury, C. M., Hope, T. A., & Behr, S. C. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001569 · Cited by 30
DiPippo, V. A., Nguyen, H. M., Brown, L. G., Olson, W. C., Vessella, R. L., & Corey, E. (2015) · The Prostate · doi:10.1002/pros.23124 · Cited by 29
See the unseen: Mesorectal lymph node metastases in prostate cancer
Hijazi, S., Meller, B., Leitsmann, C., Strauß, A., Ritter, C. O., Lotz, J., Meller, J., Trojan, L., & Sahlmann, C. (2016) · The Prostate · doi:10.1002/pros.23168 · Cited by 29
Subcutaneous Lobular Capillary Hemangioma on 68Ga-PSMA PET/CT
Jochumsen, M. R., Vendelbo, M. H., Høyer, S., & Bouchelouche, K. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001542 · Cited by 29
Strong PSMA Radioligand Uptake by Rectal Carcinoma
Stoykow, C., Huber-Schumacher, S., Almanasreh, N., Jilg, C. A., & Ruf, J. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001484 · Cited by 27
Gupta, M., Choudhury, P., Gupta, G., & Gandhi, J. S. (2016) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.183615 · Cited by 25
Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT
Chan, M., Schembri, G. P., & Hsiao, E. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001423 · Cited by 24
Derlin, T., Weiberg, D., & Sohns, J. M. S. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001413 · Cited by 14
Cited by
Fendler, W. P., Calais, J., Eiber, M., Flavell, R. R., Mishoe, A., Feng, F. Y., Nguyen, H. G., Reiter, R. E., Rettig, M. B., Okamoto, S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0096 · Cited by 779
Self-citationEiber, M., Herrmann, K., Calais, J., Hadaschik, B., Giesel, F. L., Hartenbach, M., Hope, T., Reiter, R., Maurer, T., Weber, W. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198119 · Cited by 626
Self-citationImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Calais, J., Ceci, F., Cho, S. Y., Fanti, S., Giesel, F. L., Goffin, K., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06089-w · Cited by 410
Self-citationE-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Ceci, F., Oprea-Lager, D. E., Emmett, L., Adam, J. A., Bomanji, J., Czernin, J., Eiber, M., Haberkorn, U., Hofman, M. S., Hope, T. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05245-y · Cited by 368
Self-citation
Metadata
- Authors
- Sheikhbahaei, S., Afshar-Oromieh, A., Eiber, M., Solnes, L. B., Javadi, M. S., Ross, A. E., Pienta, K. J., Allaf, M. E., Haberkorn, U., Pomper, M. G., Gorin, M. A., & Rowe, S. P.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2017-08-01
- Volume
- 44
- Issue
- 12
- Pages
- 2117-2136
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2740524391
- Cited by
- 295
- References
- 123
- FWCI
- 25.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.